Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ayers

Showing results (121-130 of 225) with videos related to

Pageof 23
Sort By:
Scientific Reports|July 22, 2023
Descriptive norms caused increases in mask wearing during the COVID-19 pandemicSamantha L Heiman, Scott Claessens, Jessica D Ayers, et al.
NPJ Precision Oncology|January 21, 2022
Proximity of immune and tumor cells underlies response to BRAF/MEK-targeted therapies in metastatic melanoma patientsChi Yan, Sheau-Chiann Chen, Gregory D Ayers, et al.
Magnetic Resonance Imaging|February 25, 2014
A comparison of two methods for estimating DCE-MRI parameters via individual and cohort based AIFs in prostate cancer: a step towards practical implementationAndriy Fedorov, Jacob Fluckiger, Gregory D Ayers, et al.
AJR. American Journal of Roentgenology|April 24, 2007
Comparison of CT methods for determining the fat content of the liverYoshihisa Kodama, Chaan S Ng, Tsung T Wu, et al.
Science (New York, N.Y.)|September 6, 1991
Synchrotron X-ray Diffraction from a Microscopic Single Crystal Under PressureE F Skelton, J D Ayers, S B Qadri, et al.
Cancer Research|October 23, 2014
Myeloid IKKβ promotes antitumor immunity by modulating CCL11 and the innate immune responseJinming Yang, Oriana E Hawkins, Whitney Barham, et al.
Cancer|January 15, 1994
Paratesticular rhabdomyosarcoma: delayed effects of multimodality therapy and implications for current managementL L Hughes, M J Baruzzi, R C Ribeiro, et al.
Cancers|July 29, 2023
Generation of Orthotopic Patient-Derived Xenografts in Humanized Mice for Evaluation of Emerging Targeted Therapies and Immunotherapy Combinations for MelanomaChi Yan, Caroline A Nebhan, Nabil Saleh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 23, 1998
A phase I-II study of bi-weekly paclitaxel as first-line treatment in metastatic breast cancerK A Gelmon, A Tolcher, S O'Reilly, et al.
Plos One|April 5, 2013
Limits of [18F]-FLT PET as a biomarker of proliferation in oncologyEliot T McKinley, Gregory D Ayers, R Adam Smith, et al.
Pageof 23

Showing results (121-130 of 225) with videos related to

Sort By:
Pageof 23
Scientific Reports|July 22, 2023
Descriptive norms caused increases in mask wearing during the COVID-19 pandemicSamantha L Heiman, Scott Claessens, Jessica D Ayers, et al.
NPJ Precision Oncology|January 21, 2022
Proximity of immune and tumor cells underlies response to BRAF/MEK-targeted therapies in metastatic melanoma patientsChi Yan, Sheau-Chiann Chen, Gregory D Ayers, et al.
Magnetic Resonance Imaging|February 25, 2014
A comparison of two methods for estimating DCE-MRI parameters via individual and cohort based AIFs in prostate cancer: a step towards practical implementationAndriy Fedorov, Jacob Fluckiger, Gregory D Ayers, et al.
AJR. American Journal of Roentgenology|April 24, 2007
Comparison of CT methods for determining the fat content of the liverYoshihisa Kodama, Chaan S Ng, Tsung T Wu, et al.
Science (New York, N.Y.)|September 6, 1991
Synchrotron X-ray Diffraction from a Microscopic Single Crystal Under PressureE F Skelton, J D Ayers, S B Qadri, et al.
Cancer Research|October 23, 2014
Myeloid IKKβ promotes antitumor immunity by modulating CCL11 and the innate immune responseJinming Yang, Oriana E Hawkins, Whitney Barham, et al.
Cancer|January 15, 1994
Paratesticular rhabdomyosarcoma: delayed effects of multimodality therapy and implications for current managementL L Hughes, M J Baruzzi, R C Ribeiro, et al.
Cancers|July 29, 2023
Generation of Orthotopic Patient-Derived Xenografts in Humanized Mice for Evaluation of Emerging Targeted Therapies and Immunotherapy Combinations for MelanomaChi Yan, Caroline A Nebhan, Nabil Saleh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 23, 1998
A phase I-II study of bi-weekly paclitaxel as first-line treatment in metastatic breast cancerK A Gelmon, A Tolcher, S O'Reilly, et al.
Plos One|April 5, 2013
Limits of [18F]-FLT PET as a biomarker of proliferation in oncologyEliot T McKinley, Gregory D Ayers, R Adam Smith, et al.
Pageof 23